Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women
- PMID: 3113703
- DOI: 10.1007/BF02555124
Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women
Abstract
Although anabolic steroids have been used for many years to treat osteoporosis there is little available evidence about their efficacy or mode of action. These agents have recently been shown to produce an increase in total body calcium and bone density and it has been suggested that they stimulate bone formation. In this study 27 osteoporotic postmenopausal women were given 50 mg of nandrolone decanoate intramuscularly, every 2 or 3 weeks for 3 months, and the changes in forearm mineral density, fasting plasma, and urinary calcium, urinary hydroxyproline, and radiocalcium absorption were measured. Associated with a rise in forearm mineral density was a significant fall in fasting urinary calcium, but no significant change in fasting urinary hydroxyproline. The plasma calcium and phosphate fell significantly and there was a significant rise in the renal tubular reabsorption of calcium and a fall in the renal tubular reabsorption of phosphate. In a subset of 22 patients there was a significant rise in radiocalcium absorption. The results are consistent with the concept that nandrolone exerts a significant positive effect on bone formation and that this results in a fall in the fasting plasma calcium level, and consequently calcium excretion.
Similar articles
-
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.Clin Rheumatol. 1995 Sep;14 Suppl 3:32-9. doi: 10.1007/BF02210686. Clin Rheumatol. 1995. PMID: 8846659 Review.
-
[Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].Minerva Endocrinol. 1989 Jan-Mar;14(1):69-74. Minerva Endocrinol. 1989. PMID: 2659955 Clinical Trial. Italian.
-
Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.Bone. 1989;10(1):3-6. doi: 10.1016/8756-3282(89)90139-7. Bone. 1989. PMID: 2736154
-
Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.Maturitas. 1989 Sep;11(3):187-97. doi: 10.1016/0378-5122(89)90210-7. Maturitas. 1989. PMID: 2687645 Clinical Trial.
-
Calcium renal lithiasis and bone mineral density. Importance of bone metabolism in urinary lithiasis.Actas Urol Esp. 2013 Jun;37(6):362-7. doi: 10.1016/j.acuro.2012.10.003. Epub 2013 Feb 12. Actas Urol Esp. 2013. PMID: 23411066 Review. English, Spanish.
Cited by
-
Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature.Transl Androl Urol. 2020 Mar;9(Suppl 2):S186-S194. doi: 10.21037/tau.2019.11.03. Transl Androl Urol. 2020. PMID: 32257859 Free PMC article. Review.
-
Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosis.Clin Rheumatol. 1995 Sep;14 Suppl 3:32-9. doi: 10.1007/BF02210686. Clin Rheumatol. 1995. PMID: 8846659 Review.
-
[Prophylaxis and treatment of osteoporosis].Klin Wochenschr. 1989 May 15;67(10):557-8. doi: 10.1007/BF01719785. Klin Wochenschr. 1989. PMID: 2739351 German. No abstract available.
-
Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.Osteoporos Int. 1997;7(1):29-35. doi: 10.1007/BF01623456. Osteoporos Int. 1997. PMID: 9102059 Clinical Trial.
-
Attenuation of Bone Mineral Density Decline During Anemia Treatment With Methenolone Acetate in Myelodysplastic Syndrome.JCEM Case Rep. 2024 Apr 15;2(4):luae055. doi: 10.1210/jcemcr/luae055. eCollection 2024 Apr. JCEM Case Rep. 2024. PMID: 38623532 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical